AAAAAA

   
Results: 1-10 |
Results: 10
Fluoxetine treatment in patients with recurrent brief depression
Authors: Stamenkovic, M Blasbichler, T Riederer, F Pezawas, L Brandstatter, N Aschauer, HN Kasper, S
Citation: M. Stamenkovic et al., Fluoxetine treatment in patients with recurrent brief depression, INT CLIN PS, 16(4), 2001, pp. 221-226
Recurrent brief depressive episodes - epidemiology, clinical diagnostics, and therapy
Authors: Pezawas, L Stamenkovic, M Kasper, S
Citation: L. Pezawas et al., Recurrent brief depressive episodes - epidemiology, clinical diagnostics, and therapy, NERVENARZT, 72(3), 2001, pp. 169
Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance
Authors: Pezawas, L Quiner, S Moertl, D Tauscher, J Barnas, C Kufferle, B Wolf, R Kasper, S
Citation: L. Pezawas et al., Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance, INT CLIN PS, 15(4), 2000, pp. 207-214
Central nervous activation in opoid dependent patients evaluated by means of Fourier analysis of pupillary oscillations
Authors: Grunberger, J Linzmayer, L Fischer, G Pezawas, L Stohr, H Grunberger, M
Citation: J. Grunberger et al., Central nervous activation in opoid dependent patients evaluated by means of Fourier analysis of pupillary oscillations, WIEN KLIN W, 112(2), 2000, pp. 75-79
In vivo I-123 IBZM SPECT imaging of striatal dopamine-2 receptor occupancyin schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol
Authors: Tauscher, J Kufferle, B Asenbaum, S Fischer, P Pezawas, L Barnas, C Tauscher-Wisniewski, S Brucke, T Kasper, S
Citation: J. Tauscher et al., In vivo I-123 IBZM SPECT imaging of striatal dopamine-2 receptor occupancyin schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol, PSYCHOPHAR, 141(2), 1999, pp. 175-181
Buprenorphine versus methadone maintenance for the treatment of opioid dependence
Authors: Fischer, G Gombas, W Eder, H Jagsch, R Peternell, A Stuhlinger, G Pezawas, L Aschauer, HN Kasper, S
Citation: G. Fischer et al., Buprenorphine versus methadone maintenance for the treatment of opioid dependence, ADDICTION, 94(9), 1999, pp. 1337-1347
Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia
Authors: Kasper, S Tauscher, J Kufferle, B Barnas, C Pezawas, L Quiner, S
Citation: S. Kasper et al., Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia, EUR ARCH PS, 249, 1999, pp. 83-89
The use of the antioxidant tirilazad mesylate in human liver transplantation: is there a therapeutic benefit?
Authors: Plochl, W Krenn, CG Pokorny, H Pezawas, L Pezawas, T Steltzer, H
Citation: W. Plochl et al., The use of the antioxidant tirilazad mesylate in human liver transplantation: is there a therapeutic benefit?, INTEN CAR M, 25(6), 1999, pp. 616-619
Receptor test (pupillary dilatation after application of 0.01% tropicamidesolution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease
Authors: Grunberger, J Linzmayer, L Walter, H Rainer, M Masching, A Pezawas, L Saletu-Zyhlarz, G Stohr, H Grunberger, M
Citation: J. Grunberger et al., Receptor test (pupillary dilatation after application of 0.01% tropicamidesolution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease, NEUROPSYCHB, 40(1), 1999, pp. 40-46
Outpatient opiate detoxification treatment with buprenorphine - Preliminary investigation
Authors: Diamant, K Fischer, G Schneider, C Lenzinger, E Pezawas, L Schindler, S Eder, H
Citation: K. Diamant et al., Outpatient opiate detoxification treatment with buprenorphine - Preliminary investigation, EUR ADDIC R, 4(4), 1998, pp. 198-202
Risultati: 1-10 |